Compounds > 3,3'-diselenodipropionic acid
Page last updated: 2024-12-06

3,3'-diselenodipropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,3'-diselenodipropionic acid: a free radical scavenger; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23837
SCHEMBL ID1976191
MeSH IDM0516472

Synonyms (22)

Synonym
propionic acid, 3,3'-diselenodi-
diselenodipropionic acid
propanoic acid, 3,3'-diselenobis-
diselenium-dipropionic acid
bis(carboxyethyl) diselenide
brn 1778850
3-(2-carboxyethyldiselanyl)propanoic acid
7370-58-3
unii-2sp2qs73w9
3',3-diselenodipropionic acid
4-03-00-00753 (beilstein handbook reference)
2sp2qs73w9 ,
SCHEMBL1976191
DTXSID40224006
.beta.,.beta.'-diselenodipropionic acid
diseleno-3,3'-dipropionic acid
AXJLEYVRLPNPGF-UHFFFAOYSA-N
3,3'-diselenodipropionic acid
3,3'-diselenobispropionic acid
3,3'-diselanediyldipropanoic acid
3',3-diseleno dipropionic acid
3,3'-diselanediyldipropanoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's10 (66.67)24.3611
2020's4 (26.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.45 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
2,2'-azobis(2-amidinopropane)
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator		2.0310monoazo compound
ebselen
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.		2.0310benzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
selenocystine
selenocystine: RN given refers to parent cpd; structure		2.2110diselenide;
selenoamino acid
sodium sulfate
[no description available]		7.610inorganic sodium salt
sodium selenite
disodium selenite : An inorganic sodium salt composed of sodium and selenite ions in a 2:1 ratio.		2.0310inorganic sodium salt;
selenite salt		nutraceutical
cystine
[no description available]		2.2110
sulfur
Sulfur: An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight [32.059; 32.076]. It is found in the amino acids cysteine and methionine.		2.1110chalcogen;
nonmetal atom		macronutrient
selenocysteine
Selenocysteine: A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid.. selenocysteine : An alpha-amino acid that consists of alanine where one of the methyl hydrogens is substituted with a seleno group.		2.5220
ConditionIndicatedRelationship StrengthStudiesTrials
Colitis Gravis
[description not available]		04.2190
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		04.22100
Colitis, Ulcerative
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.		04.2190
Cancer of Lung
[description not available]		02.7220
Lung Neoplasms
Tumors or cancer of the LUNG.		02.7220
Experimental Lung Inflammation
Inflammation of any part, segment or lobe, of the lung parenchyma.		02.2110
Injuries, Radiation
[description not available]		02.2110
Pneumonia
Infection of the lung often accompanied by inflammation.		02.2110
Kidney Diseases
Pathological processes of the KIDNEY or its component tissues.		02.1710
Fibrosis, Radiation
[description not available]		02.0810
Innate Inflammatory Response
[description not available]		02.4820
Experimental Radiation Injuries
[description not available]		02.4720
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.		02.4820
Radiation Pneumonitis
Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.		02.0810
Malignant Melanoma
[description not available]		02.110
Cancer of Skin
[description not available]		02.110
Melanoma
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)		02.110
Skin Neoplasms
Tumors or cancer of the SKIN.		02.110
Chromosome-Defective Micronuclei
[description not available]		02.110
Extravascular Hemolysis
[description not available]		02.0310
Hemolysis
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.		07.0310